Trial intelligence / Profile preview

Seasonal Malaria Vaccine delivery research in Mali

PACTR202505726361548Phase 4Recruiting

Sponsor
Université des Sciences, des Techniques et des Technologies de Bamako
Start
Feb 2025
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, open-label trial of R21/Matrix-M in malaria (2 arms), sponsored by Université des Sciences, des Techniques et des Technologies de Bamako. Started Feb 2025; status: recruiting.

02

Drugs

R21/Matrix-M
03

Conditions

malaria

Beyond the preview

Go deeper on PACTR202505726361548.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202505726361548.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call